A recent press release reports, “HTG Molecular Diagnostics, Inc., a diagnostic company whose mission is to advance precision medicine, today announced the release of its HTG EdgeSeqTM Reveal data analytics software, version 1.2.0. HTG EdgeSeq Reveal is a powerful software product that can enable customers to streamline their analysis of samples processed on the HTG EdgeSeq platform. The new release contains enhanced functionality enabling data analysis from the HTG EdgeSeq Precision Immuno‑Oncology Panel, the HTG EdgeSeq Oncology Biomarker Panel, and the newly released HTG EdgeSeq Mouse mRNA Tumor Response Panel. Together with HTG EdgeSeq molecular profiling assays, customers using the new HTG EdgeSeq Reveal software product will have the ability to more rapidly draw conclusions from their data and to generate charts representing their discoveries.”
John Lubniewski, President and CEO of HTG, commented, “Our customers asked for a powerful data analysis tool for use with our research use only (RUO) assays; we listened and delivered. HTG EdgeSeq Reveal allows our customers to quickly assess the quality and biological relevance of their data generated from our HTG EdgeSeq RUO assays… With this new release, we have expanded the applications and utility of data analytics capabilities, including pathway assessment tools. Our innovative HTG EdgeSeq Reveal data analysis suite is a scalable, flexible data product that we believe will continue to expand with new assays and applications to support HTG’s growing product portfolio.”
Read more at Nasdaq.
Image used under license from Shutterstock.com